Dr. Kazem Kazempour

Dr. Kazem Kazempour began his scientific career in mathematical statistics, publishing early research on genetics in 1979. His passion for public safety led him to the U.S. Food and Drug Administration as a statistical reviewer. At the FDA, he earned multiple awards for his innovative work on critical trial designs, including key treatments for HIV/AIDS.

Seeing a need for better global trial standards, Dr. Kazempour transitioned to industry leadership. He directed global biometrics at major pharmaceutical firms and co-founded Amarex Clinical Research in 1998. Over 30 years, he has contributed to over 100 clinical trials and hundreds of FDA advisory meetings across vaccines, antivirals, and heart health.

Today, Dr. Kazempour passes his knowledge to the next generation as an adjunct professor at George Washington University. He created Dr. Kazem Kazempour Epidemiology to give you direct access to world-class science, helping you navigate health decisions with clear facts.